GWPH

GW Pharmaceuticals PLC

GW Pharmaceuticals PLC is a biopharmaceutical company that specializes in developing and commercializing innovative therapeutics from its proprietary cannabinoid product platform. Its flagship product, Epidiolex, is the first FDA-approved prescription cannabidiol (CBD) medicine for treating seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome in patients aged two years and above. The company is also working on a pipeline of cannabinoid-based medicines for treating various diseases, such as autism spectrum disorders, glioma, and schizophrenia. GW Pharmaceuticals is dedicated to advancing the science of cannabinoid-based medicines and enhancing the quality of life for patients suffering from debilitating conditions.

Instrument specification in OANDA

Name
Currency
Symbol
Minimum order value
Ticker
Trading hours
Type
Hours of accepting orders
ISIN

Start trading now with fast account opening.

Sign-up now to trade the most active markets

Open account
Boasting over 20 years in the markets, leading analysis tools and thousands of satisfied clients, OANDA is proud to be an award-winning broker.
Get access to the most active of global markets with thousands of trading instruments at your fingertips, as well leading technical tools to assist in your analysis.
Trade without unnecessary costs and total pricing transparency - OANDA offers zero-commission on major instruments, transparent pricing.
Scroll to top